0001140361-16-047412.txt : 20160111 0001140361-16-047412.hdr.sgml : 20160111 20160111115657 ACCESSION NUMBER: 0001140361-16-047412 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160111 DATE AS OF CHANGE: 20160111 EFFECTIVENESS DATE: 20160111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sapience Therapeutics, Inc. CENTRAL INDEX KEY: 0001661731 IRS NUMBER: 475419141 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254854 FILM NUMBER: 161335632 BUSINESS ADDRESS: STREET 1: 73 MARKET STREET STREET 2: SUITE 376 CITY: YONKERS STATE: NY ZIP: 10710 BUSINESS PHONE: 914-226-3432 MAIL ADDRESS: STREET 1: 73 MARKET STREET STREET 2: SUITE 376 CITY: YONKERS STATE: NY ZIP: 10710 D 1 primary_doc.xml X0707 D LIVE 0001661731 Sapience Therapeutics, Inc. 2 Overhill Road Scarsdale NY NEW YORK 10583 914-607-6931 DELAWARE None None Corporation true 2015 Barry Kappel, Ph.D. 2 Overhill Road Scarsdale NY NEW YORK 10583 Executive Officer Director Isaac Blech 2 Overhill Road Scarsdale NY NEW YORK 10583 Director David Scheinberg, Ph.D. 2 Overhill Road Scarsdale NY NEW YORK 10583 Director Robert Ruffolo, Ph.D. 2 Overhill Road Scarsdale NY NEW YORK 10583 Director Biotechnology Decline to Disclose 06b false 2015-12-28 false true false 0 1000000 300000 700000 false 3 0 0 0 false Sapience Therapeutics, Inc. /s/ Barry Kappel Barry Kappel Chief Executive Officer 2016-01-11